Market Analysis
The global coronary stents market is projected to touch USD 9,382.63 million at a stupendous 7.81% CAGR over the predicted years (2018-2023). Coronary stents are utilized in angioplasty for making cross-section of blood vessels wider. The stent will reduce the chest pain along with recovering survivability during acute myocardial infarction. Coronary stents are used for treating cardiac diseases namely coronary artery disease, angina pain and myocardial infarction.
Get request free sample @ https://www.marketresearchfuture.com/sample_request/5915
There are many factors that is driving the growth of the coronary stents market. Some of these factors as per the Market Research Future (MRFR) report include increasing prevalence of CAD (coronary artery disease, innovations in coronary stents, increase in research and development of coronary stems, untapped emerging countries offering new market opportunities, lifestyle change diseases, increasing geriatric population, profound increase in healthcare coverage, advanced medical technologies, development of ICT (information and communication technology) and increase in government investment. On the contrary, factors such as high expenditure of procedures related to coronary stents coupled with accessibility of substitutes for CAD treatment is likely to hinder the growth of the
coronary stents market.
Market Segmentation
Market Research Future report offers an all-inclusive segmental analysis of the coronary stents market on the basis of products and end user.
Based on products, it is segmented into Bioresorbable Vascular Scaffolds, Bare Metal Stents and Drug Eluting Stents. Of these, drug eluting stent is expected to lead the market during the predicted years owing to its increasing acceptance in better patient compliance, angioplasty procedures in comparison to bare metal stents. The bioresorbable stents is expected to expand at the fastest pace.
Based on end users, the coronary stents market is segmented into specialty centers, ambulatory surgical centers, hospitals and clinics and others. Of these, hospitals and clinics will have the maximum market share during the predicted years. This will be followed by the ambulatory surgical centers which will expand at the fastest rate.
Regional Analysis
Based on region, the coronary stents market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will have a lion’s share in the market due to increasing cases of cardiovascular diseases mainly coronary artery disease, arterial blockage, cardiac arrythmia to name a few. Availability of advanced treatment methods and better therapeutic approaches has affected the growth of the market in this region in a positive way. The other factors that is driving the growth of the coronary stents market here include high disposable income, increasing medical awareness among the people here and existence of leading medical device manufacturers in this region. The coronary stents market in Europe holds the second largest share owing to the increasing support by the government for device manufacturers. Also, expansion of the companies geographically has resulted in a broader reach of medical services and products that has brought tremendous change with regards to acceptance as well as implementation of novel procedures and products. The coronary stents market in the APAC region experienced a huge growth due to the increasing development in the medical domain in the developing countries such as China and India. Besides, increasing medical device companies here, increasing research and development expenditure and increasing funding made by the government has resulted in its fastest growth. On the other hand, the coronary stents market in the Middle East and Africa is expected to have minimal growth opportunities.
Competitive Analysis
The coronary stents market is fragmented and highly competitive. The leading companies which have used strategies such as strategic alliances and mergers and acquisitions have gained a competitive advantage. Besides companies are highly focused to create products that are technologically advanced and deliver efficiency and greater accuracy.
Key Players
Leading players profiled in the coronary stents market include Terumo Corporation, Stentys SA, MicroPort Scientific Corporation, Meril Life Sciences, Medtronic plc, Elixir Medical Corporation, Cook Medical, R. Bard, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, and Abbott, B. Braun Melsungen AG.
Feb 2019- Biotronik has received approval from the FDA on its Ultrathin Orsiro Stent to treat coronary artery disease. This coronary stent will offer a novel treatment option to healthcare providers that will help in sealing the perforation to prevent blood leakage at the time of the procedure as well as avoid higher invasive surgical procedure or life-threatening complication.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/coronary-stent-market-5915
Related reports link:-
Clinical Nutrition Market
Blood Testing Market
Medical Device Connectivity Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Competitive Analysis:The major players operating in the Glass Additives Market include Namibia Rare Earths Inc. (Canada), Lynas Corporation Ltd (Australia), Torrecid Group (Spain), Potters Industries LLC (U.S.), SCHOTT AG (Germany), DuPont.
(U.S.), GILLINDER GLASS (U.S.), METALL RARE EARTH LIMITED (China), Ardagh Group (Republic of Ireland), HAMMOND GROUP INC (U.S.) among others.Access Complete Report @ https://www.marketresearchfuture.com/reports/glass-additives-market-5140Market Segmentation:The Global Glass Additives Market is segmented on the basis of product, application, and region.
On the basis of product, the market is categorized into metal oxide, nanoparticles, and polymers & rare earth metals.
As these are used for coloring and to enhance specific properties such as electrical and thermal conductivity.
As these are mainly used as coating for gadgets, windows, and doors.
Increasing popularity of scratch resistant window panes for mobile phones, automobiles, laptops, and other electronic devices is predicted to surge the market growth.
Market Overview:Increasing demand for dietary supplements and nutritive food & feed is one of the major factors contributing to the growth of the global glycinates market.
Glycinates are serving as an important additive in most of the food, beverage, supplements, and animal feed products.
Availability of glycinates in various forms has influenced the demand from various industries apart from food & feed industry.Access Report Details @ https://www.marketresearchfuture.com/reports/glycinates-market-5546Market Forecast:The global glycinates market share in the foods & feed industry is intensifying by the growing demand for functional food & feed additives in the developed & developing countries.
Increasing prevalence of deficiency diseases among the growing population is found to be a key factor responsible for the growth of glycinates market.Furthermore, improved processing methods and demand for nutritive food products in the developing countries are positively supporting the growth of the global glycinates market.
Additionally, restriction on the use of antibiotics in food & feed formulations in the North American & European region is adding fuel to the market growth.
Downstream analysis:The global glycinates market is segmented into type, form, and application.On the basis of the type, it is segmented into zinc, copper, manganese, magnesium, calcium, sodium, and others.
The Global Sportswear Market is projected to display a robust growth represented by a CAGR of 5.80% during 2018-2023.
Athletic Footwear segment contributed maximum revenue in the market and is expected to continue the leadership in the forecast period on the back of rising awareness regarding the rising awareness of health and wellness, the prevalence of Athleisure trend in developing nations coupled with increasing number gyms, jogging tracks, fitness clubs.
Amidst the Sales Channel, online segment is expected to witness the fastest growth rate on the heels of rising internet penetration and number of smartphone users across the globe.
Amongst the regions, Asia Pacific accounts for the largest regional share in the global sportswear market in 2018.
Key factors driving the robust Asia Pacific market include large population base, increasing disposable income coupled with rising health consciousness across the region.
Global Sportswear Market has covered and analyzed the potential of Global Sportswear Market and provides statistics and information on market size, shares and growth factors.
Market Overview:Increasing demand for dietary supplements and nutritive food & feed is one of the major factors contributing to the growth of the global glycinates market.
Glycinates are serving as an important additive in most of the food, beverage, supplements, and animal feed products.
Availability of glycinates in various forms has influenced the demand from various industries apart from food & feed industry.Competitive analysisThe major players in the glycinates marketAjinomoto Co., Inc. (Japan)Clariant AG (Switzerland)Solvay SA (Belgium)BASF SE (Germany)NovoTech Nutraceuticals Inc. (U.S.)Dunstan Nutrition Ltd. (New Zealand)Shijiazhuang Donghua Jinlong Chemical Co Ltd. (China)Schaumann GmbH & Co. KG.
(Germany)Aliphos Belgium SA/NV (Belgium)Albion Laboratories, Inc. (U.S.)Market Forecast:The global market share in the foods & feed industry is intensifying by the growing demand for functional food & feed additives in the developed & developing countries.
Increasing prevalence of deficiency diseases among the growing population is found to be a key factor responsible for the growth of glycinates market.Furthermore, improved processing methods and demand for nutritive food products in the developing countries are positively supporting the growth of the global market.
Additionally, restriction on the use of antibiotics in food & feed formulations in the North American & European region is adding fuel to the market growth.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Market Analysis The global biologics market, during the forecast period, will register growth at a CAGR of 6.95%.The market for biologics is set to reach USD 285,520.4 million by 2023.
Analysts have also studied the market to understand potential threats and challenges the market companies could face.
Although the market is poised to grow at a fast pace across product, disease indication, and manufacturing segments, factors such as restrictions in access to capacity could slow down the market's growth worldwide.Market Segmentation The Market Research Future report offers a complete segmental analysis of the biologics market based on manufacturing, disease indication, and product.
Regional AnalysisBy region, the biologics market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, Europe, and the Middle East and Africa.
Various factors are propelling the growth of the biologics market in the region, such as investments in new facilities for producing drugs for clinical trials, strong economic growth of Canada and the US, and rapid adoption of manufacturing technologies.
India is a major contributor in this region for its massive strides in biologics manufacturing.Key Players Notable players profiled in the biologics market report include GlaxoSmithKline Plc (UK), Eli Lilly and Company (US), Bayer AG (Germany), Sanofi (France), F. Hoffman-La Roche AG (Switzerland), Novartis AG (Switzerland), Amgen (US), Pfizer Inc. (US), AstraZeneca (UK), and AbbVie, Inc. (US).
